Home > Newsletters > Drug Industry Daily > EpiCept Gets Fast-Track Designation for Neuropathic Pain Product
Drug Industry Daily
April 11, 2012 | Vol. 11 No. 72
EpiCept Gets Fast-Track Designation for Neuropathic Pain Product
EpiCept’s neuropathic pain product AmiKet has received fast-track designation after the agency waived several non-clinical toxicology studies planned in support of the drug.
Report Predicts More Use of Drug Special Designations in 2013FDA, EU Likely to Increase Use of Special Designations to Speed Approvals in 2013, Tufts SaysPossible FDA Approval of New Pain Drug Using Other Drug’s Data May Save Struggling NeurogesXGilead’s PAH Candidate Scrapped After Missing Primary Endpoint in Study
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.